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A single-nucleotide polymorphism (rs2274223: A5780G:His1927Arg) in the phospholipase C epsilon gene (PLCe)
was recently identified as a susceptibility locus for esophageal cancer in Chinese subjects. To determine the underlying
mechanisms of PLCe and this SNP in esophageal carcinogenesis, we analyzed PLCe genotypes, expression, and their
correlation in esophageal cancer cell lines, non-transformed esophageal cells, 58 esophageal squamous cell carcinomas
and 10,614 non-cancer subjects from China. We found that the G allele (AG or GG) was associated with increased
PLCe mRNA and protein expression in esophageal cancer tissues and in esophageal cancer cell lines. G allele was also
associated with higher enzyme activity, which might be associated with increased protein expression. Quantitative
analysis of the C2 domain sequences revealed that A:G allelic imbalance was strongly linked to esophageal malignan-
cy. Moreover, the analysis of 10,614 non-cancer subjects demonstrated that the G allele was strongly associated with
moderate to severe esophagitis in the subjects from the high-incidence areas of China (OR 6.03, 95% CI 1.59–22.9 in
high-incidence area vs. OR 0.74, 95% CI 0.33–1.64 in low-incidence area; P ¼ 0.008). In conclusion, the PLCe gene,
particularly the 5780G allele, might play a pivotal role in esophageal carcinogenesis via upregulating PLCe mRNA,
protein, and enzyme activity, and augmenting inflammatory process in esophageal epithelium. Thus, 5780G allele
may constitute a promising biomarker for esophageal squamous cell carcinoma risk stratification, early detection, and
progression prediction.  2013 Wiley Periodicals, Inc.
Key words: phospholipase C epsilon; esophageal cancer; esophagitis
Additional supporting information may be found in the online
version of this article.
Abbreviations: PLCe, phospholipase C epsilon; SCC, squamous cell
carcinoma; LPA, 1-Oleoyl-L-a-lysophosphatidic acid; RT-PCR, reverse
transcriptional polymerase chain reaction.
Contract grant sponsor: National Institutes of Health, USA; Con-
tract grant number: CA112081 (to W. Yang); Contract grant spon-
sor: ; Contract grant number: CA146799 and DK087454 (to S.J.
Meltzer); Contract grant sponsor: Xinxiang Medical University Key
Scientific Program 2009-5; Contract grant sponsor: China National
Natural Science Foundation; Contract grant numbers: 30670956;
30971133 (to L.D. Wang); 91229115 (to W. Yang); Contract grant
sponsor: Program of Liaoning Excellent Talents in University
(LETU); Contract grant number: LJQ2011002 (to X. Bi); Contract
grant sponsor: Intramural Research Program of the NIH/National In-
stitute of Environmental Health Sciences (to S. Shears).
Conflict of interest: nothing to declare.
The sponsors of this study had no role in study design, data
collection and analysis, decision to publish, or preparation of the
manuscript.
Li-Dong Wang and Xiuli Bi contributed equally to this work.
*Correspondence to: Department of Pathology, Xinxiang Medical
University, Xinxiang 453003, China.
Received 23 June 2012; Revised 13 January 2013; Accepted 18
January 2013
DOI 10.1002/mc.22016
Published online 6 February 2013 in Wiley Online Library
(wileyonlinelibrary.com).
 2013 WILEY PERIODICALS, INC.
INTRODUCTION
Phospholipase C epsilon (PLCe or PLCE 1) is a
phosphoinositide-specific enzyme phospholipase C
that converts phosphatidylinositol 4,5-biphosphate
(PtdIns (4, 5) P2) [1,2] to two intracellular second
messengers, diacylglycerol and inositol 1,4,5-tri-
sphosphate, which regulate protein kinase C activity
and calcium mobilization, respectively [3,4]. These
responses are involved in the regulation of cell
growth, differentiation, and oncogenesis [5]. To
date, six members of the PLC family (PLCb, g, d, e,
h, and z) have been identified in mammalian cells.
These members share similar catalytic properties
and are characterized by distinct regulatory mecha-
nisms [6,7], indicating that PLCs exert diverse func-
tions in carcinogenesis. PLCe binds to and is
activated by the Ras family GTPases [1,8,9]. It partic-
ipates in murine skin cancer development through
augmentation of inflammatory cytokine production
and signaling [10–12]. A more recent report also
showed that inhibition of intestinal tumorigenesis
in ApcMin/þ mice by loss of PLCe occurs via reduc-
ing cytokine-mediated inflammation in local tissue
[13]. However, the involvement of PLCe in human
carcinogenesis, particularly in esophageal cancer,
was not been recognized until a susceptible SNP was
recently identified in GWAS studies of more than
20,000 Chinese subjects [14,15]. This SNP, located
within exon 26 of the PLCe gene at chromosome
10q23, leads to a nonsynonymous alteration from
CAC (A allele, encoding histidine) to CGC (G allele,
encoding arginine). These previous data showed
that a G at position 5780 in the C2 domain of PLCe
was associated with an increased risk of both squa-
mous cell carcinoma (SCC) and esophagus-cardia
gastric adenocarcinoma (ECA). In the current report,
we demonstrate that the presence of the G allele at
this locus leads to increased PLCe mRNA and protein
expression and enzyme activity in esophageal can-
cer cells in vitro, and that A:G allelic imbalance is
strongly associated with esophageal malignancy in
primary human tissues. Interestingly, we show that
the presence of the G allele is also strongly associat-
ed with moderate to severe esophagitis in non-
cancer subjects from the areas of high-incidence of
esophageal cancer in China.
MATERIALS AND METHODS
Human Subjects
Frozen tissues from 58 esophageal SCCs and white
blood cell DNA from 10,614 non-cancer subjects
were collected from an ongoing hospital-based SCC
and EAC case–control study, involving multiple hos-
pitals throughout high- and low-risk areas for esoph-
ageal SCC in China since 2007. The genotypes of
PLCE in non-SCC patients were based on TaqMan
genotyping methods, as described recently [14]. All
subjects had undergone esophagogastroduodeno-
scopy, and non-cancer subjects with esophagitis
were determined by endoscopic examination and
histopathology. The diagnosis of the degree of
esophagitis was made by at least three pathologists.
All procedures were conducted according to Declara-
tion of Helsinki principles and had been approved
by respective institutional review boards.
DNA Extraction and PCR-Based PCLe Exon 26 Sequencing
Genomic DNA was extracted from the following
materials: SCC and adjacent normal esophageal epi-
thelia, esophageal SCC cell lines (TE-1, TE-2, TE-7,
TE-8, TE-12, G5, HCE4, HCE7, EC171, EC8712,
EC109, EC9706, SHEEC) and non-transformed
esophageal epithelial cell lines (HET1A, HEEpic)
using a DNA extraction kit (QIAGEN, Valencia, CA).
PCR for PLCe exon 26, in which the C2 domain is
located, was performed using the following primers:
forward (Ex26F): 50-TGTTCTTGGGATTCCTTTGC-30
and reverse (Ex26R): 50-TGCTTCTTAATTCAAC-
TTCTTTATAGG-30. The PCR product was directly se-
quenced using an ABI sequencing system (Applied
Biosystems, Inc., Foster City, CA). Allelic imbalance
was analyzed using Mutation Surveyor software
(Softgenetics, College Station, PA).
RNA Extraction, Quantitative Real-Time PCR,
Immunoblotting, and Immunohistochemical Staining
Total RNA was extracted from human esophageal
cancer cell lines and tissues, samples were then sub-
jected to reverse transcription; cDNA was used for
quantitative PCR analyses of PLCe expression at the
mRNA level. The following primers that cover the
C2 domain were used for quantitative PCR analysis:
forward 50-TGTGGAACGAGCAGTTTCTG-30 and re-
verse 50-ATCGAAGAGGC TGACATGGT-30. Cell ly-
sate was made from esophageal cancer cell lines,
followed by immunoblotting and probing with anti-
PLCe antibody (provide by Dr. J. Lomasney, North-
western University, Chicago, IL). Immunoblotting
intensities were quantified using Quanty One soft-
ware (Bio-Rad, Hercules, CA). PLCe immunohisto-
chemical staining was performed as described
recently [14], and immunohistochemical staining
was scored by at least three pathologists using the
following criteria: 0, no staining or staining area was
<10%; 1, positive area was between 10% and 50%;
and 2, positive area was more than 50%, similar as
we reported [16].
PLCe Enzyme Activity Assay
PLCe enzymatic activity was determined by mea-
surement of total [3H]inositol phosphates accumula-
tion in esophageal cancer cells containing AG and
AA alleles (TE-2, -7, -8, and -12). 1-Oleoyl-L-a-lyso-
phosphatidic acid (LPA) was purchased from Sigma–
Aldrich (St. Louis, MO) and dissolved in water con-
taining 1.0% fatty acid-free bovine serum albumin.
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Briefly, cells were seeded in a 24-well plate at a den-
sity of 200,000 cells per well. 18 h later, medium
was replaced with inositol- and serum-free DMEM
containing 1 mCi/well [3H]myo-inositol (American
Radiolabeled Chemicals, St. Louis, MO). Phospholi-
pase C activity was quantified 16 h after labeling by
incubation in inositol-free DMEM containing
10 mM LiCl, either in the absence of LPA or in the
presence of 10 mM LPA. The reaction was stopped
after 30 min by aspiration of the medium and addi-
tion of an ice-cold buffer containing 0.6 M
perchloric acid and 0.2 mM IP6. After neutralization
with buffer containing 1 M K2CO3 and 40 mM
EDTA, the accumulation of [3H] inositol phosphates
was quantified by Dowex chromatography. 0.1%
Triton X-100/0.1 M NaOH was added to cells in
each well to determine total lipids. Each experiment
was performed in triplicate, and these triplicate
experiments were also repeated independently three
times.
RESULTS AND DISCUSSION
To investigate whether the G allele of the PLCe
gene SNP at position 5780 alters PLCe expression,
we determined PLCe genotypes and mRNA levels in
13 human esophageal squamous cancer cell lines
(TE-1, TE-2, TE-7, TE-8, TE-12, G5, HCE4, HCE7,
EC171, EC8712, EC109, EC9706, SHEEC). Six SCC
cell lines (G5, TE-8, TE-12, HCE4, EC171, EC8712)
were AA, while the remaining 7 (TE-1, TE-2, TE-7,
HCE7, EC109, EC9706, SHEEC) were AG for PLCe at
position 5780. Quantitative RT-PCR (qRT-PCR)
revealed that PLCe mRNA levels in the seven SCC
AG cell lines increased approximately 37-fold rela-
tive to the 6 AA SCC cell lines (Figure 1A; 271  144
in AG cells vs. 7.3  3.3 in AA cells, P < 0.01).
Increased PLCe mRNA levels also correlated with
higher PLCe protein levels measured by immuno-
blotting (Figure 1B). The overall (average) intensity
of PLCE1 protein in AG cell lines were higher than
those in the AA cell lines (P < 0.02). Interestingly,
two immortalized human esophageal epithelial cell
lines derived from normal cells, HET1A (AG allele)
and HEEPic (AA allele) also exhibited a similar asso-
ciation pattern: cells with the AG allele expressed
higher levels of PLCe mRNA (23.6 in HET1A vs. 3.6
in HEEPic) and protein (data not shown).
We then examined whether elevated PLCe mRNA
and protein levels correlated with PLCe enzyme ac-
tivity. For these experiments, we chose the two AG
cell lines (TE-7 and TE-2) that expressed the highest
levels of PLCe and the two AA cell lines (TE-8 and
Figure 1. Correlation of A5780G genotypes with PLCe mRNA, to-
tal protein and enzyme activity levels in SCC cell lines. (A) Quantita-
tive determination of PLCe mRNA levels in SCC cell lines (n ¼ 13)
by qRT-PCR. Bars represent the mean  SD for each tumor type.P < 0.01. (B) A representative of immunoblotting showed that
PLCE1 protein levels were higher in AG cell lines (TE-2 and TE-7) and
were lower in AA cell lines (TE-8 and TE-12), using specific anti-PLCe
antibody. Histograms showed immunoblotting intensities quantified
by Quanty One software (Bio-Rad, Hercules, CA). P < 0.02, overall
(average) intensity of PLCE1 protein in AG cell lines in comparison
with those in AA cell lines. (C) PLCe enzymatic activity was deter-
mined by measurement of [3H] inositol triphosphate in esophageal
cancer cells with AA and AG alleles. Endogenous PLCe baseline activ-
ity (gray bars) was nearly twice as high in the two AG cell lines (TE-2
and TE-7) than those in the two AA cell lines (TE-8 and TE-12)
(76  20 vs. 42  7, P < 0.05). LPA was used as a ligand to stimu-
late PLCe activity, and PLCe activities were significantly induced
(black bars). Bars represent the mean  SD for three replicates of
experiments performed. P < 0.001, compared to individual cell line
without LPA treatment.
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TE-12) with the lowest levels of PLCe mRNA and
protein. Consistent with findings for protein levels,
endogenous PLCe baseline activity was nearly twice
as high in the two AG cell lines (TE-2 and TE-7)
than those in the two AA cell lines (TE-8 and TE-12)
(76  20 vs. 42  7, P < 0.05). The increased en-
zyme activities might be linked to the increased pro-
tein expression. Previous studies have demonstrated
that overexpression of activated small Rho family
GTPases leads to marked elevation of intracellular
inositol phosphate accumulation [17], and PLCe is a
direct effector of activated Rho [18]. Similarly, the
expression of G protein a-subunits Ga 12 and Ga 13
resulted in PLCe-dependent accumulation of inosi-
tol phosphates [19,20]. Therefore, agonists of G
Protein coupled receptors that couple to Ga 12 and
Ga 13, such as LPA (1-Oleoyl-L-a-lysophosphatidic
acid), activate PLCe in a Rho-dependent manner
[21]. To determine the response of PLCe activity to
LPA in cells containing different alleles (AA vs. AG),
we treated the two groups of ESCC cell lines with
LPA and surprisingly found that AG cell lines exhib-
ited only 2.5-fold average induction of PLCe activi-
ty, whereas AA cell lines were induced average
fourfold (Figure 1C; P < 0.05). This finding may
have been due to the failure of adapted AG allele
cells to fully activate PLCe after interacting with
harmful environmental factors (e.g., bile acids, bac-
terial infection, carcinogens, or other stressors),
which reduces subsequential induction of cytokine
and chemokine and development of inflammation
in esophageal epithelium as a defensive response
to the environmental detrimental stimulation. As a
consequence, the lack of fully activated PLCe en-
zyme could cause epithelial cells to produce more
PLCe mRNA and protein as a compensatory re-
sponse through a feedback mechanism. From analy-
sis of homology modeling of the PLCe C2 domain
structure, we observed that changing His1927 to
Arg in the C2 domain may affect protein–protein
interaction and/or lipid recognition, but is unlikely
to have an impact on ion binding by this enzyme
(Supplementary Figure 1). However, further investi-
gations using mutant allele plasmids are needed to
confirm this modeling result.
PLCe-mediated cell growth promotion has been
reported in various cell types [5,22,23], and the mi-
togenic effect of PLCe may facilitate cancer progres-
sion. We measured PLCe mRNA levels in 26 primary
human esophageal SCCs and adjacent normal eso-
phageal epithelial tissues by quantitative RT-PCR. As
shown in Figure 2A, PLCe mRNA levels were signifi-
cantly higher in esophageal SCCs than in adjacent
normal tissues (normal, 1.0 vs. SCC, 22.0; P < 0.01).
Consistent with these mRNA expression levels, SCC
tissues with heterozygous AG expressed 1.5-fold
higher protein levels than did homozygous AA
tissues (1.5  0.1 vs. 1.0  0.3, P < 0.05; Figure 2B),
assayed by immunohistochemical staining using an
anti-PLCe antibody (Figure 2C). Our results were dif-
ferent from recent report that showed decreased
PLCe mRNA and no changes of protein in esophage-
al cancer tissues compared to the adjacent normal
tissues, assayed by qRT-PCR and immunohistochem-
ical staining, respectively [24]. This discrepancy
could be resulted from the patients selection: our
patients were from the North Henan area, the most
high incidence area of esophageal cancer in the
world, the patients used in the recent report were
from Shanghai area [24], the low incidence area of
esophageal cancer. The different pattern of PLCe
in high- and low-incidence areas was observed in
esophagitis (Figure 3). We showed the results in
detail later. Interestingly, allelic imbalance analysis
showed an increased G allele copy number in 44%
(15/34) of AG SCC tissues when compared to
Figure 2. Genetic and expression-level alterations of PLCe in hu-
man esophageal cancer tissues. (A) Increased PLCe mRNA levels
were determined by RT-PCR in SCC tissues (n ¼ 26) compared to
adjacent normal control tissues. Bars represent the mean  SD of
tumor and adjacent normal tissues. P < 0.02. (B) Immunohisto-
chemical staining showed higher PLCe expression scores in SCC than
in adjacent normal epithelia (1.5  0.1 vs. 1.0  0.3, P < 0.05).
(C) Representative PLCe1 immunohistochemical staining in a AA SCC
(a) and an AG SCC (b). (D) Representative sequencing results showed
A5780G allelic imbalance in SCC versus normal esophageal control
epithelium using Mutation Surveyor software (Softgenetics, College
Station, PA). Red arrow indicates a gain of G allele in squamous cell
carcinoma.
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matching normal esophageal control tissues
(Figure 2D), using Mutation Surveyor software (Soft-
genetics, College Station, PA). These findings sug-
gest that G allele is associated with overexpression
of PLCe in primary SCC tissues.
Overexpression of PLCe protein and enhancement
of PLCe enzyme activity have been reported to
activate PKC and induce elevation of intracellular
calcium levels [25], leading to cytokine- or chemo-
kine-mediated inflammation in local tissues [12].
Furthermore, an association between esophagitis
and the development of esophageal squamous cell
cancer has been recognized and documented previ-
ously [26]. To investigate any possible association
between A5780G and esophageal inflammation, we
correlated SNP genotypes with presence or absence
of esophagitis in individuals with cancer (SCC) and
without cancer (non-SCC). 52 (89.7%) of the 58
SCC patients exhibited various degrees of esophagi-
tis (mild, moderate, or severe), whereas only 1517
(14.3%) of the 10,614 non-SCC subjects had any
esophagitis, determined by endoscopic examination
and confirmed by histopathology (P < 0.0001). Im-
portantly, the severity of esophagitis was associated
Figure 3. Association between PLCe genotypes and esophagitis in SCC and Non-SCC individuals. (A) The
severity of esophagitis (mild, moderate and severe) in SCC (n ¼ 58) and Non-SCC subjects (n ¼ 1,0614)
was correlated with the three PLCe genotypes. (B,C) Association between PLCe genotypes and esophagitis in
Non-SCC individuals from high- and low-risk areas. The distribution and numbers in each group are provided in
Table 1. P < 0.01.
Table 1. Association Between PLCE1 Genotypes and Esophagitis in High- and Low-Risk Areas of China
Genotypes
High-incidence area % (n) Low-incidence area % (n)
AA AG/GG OR (95% CI) AA AG/GG OR (95% CI)
Mild esophagitis 86% (126) 80% (76) 1.00 92% (296) 91% (230) 1.00
Moderate 12% (18) 9% (9) 0.84 (0.36–1.97) 3% (10) 5% (13) 1.67 (0.72–3.89)
Severe 2% (3) 11% (10) 6.03 (1.59–22.9) 5% (17) 4% (10) 0.73 (0.33–1.64)
OR, odds ratio; CI, confidence interval.
P ¼ 0.008.
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with the AG/GG allele in these SCC patients. Eight
(62%) of the 13 SCC patients with moderate or se-
vere esophagitis were AG/GG, while only 5 (38%) of
the 13 SCC patients with moderate or severe esoph-
agitis had the AA genotype (Figure 3A). However,
when non-SCC individuals with esophagitis were
classified into high- or low-incidence areas for
esophageal cancer, a significant association between
severe esophagitis and the G allele of the PLCe gene
was observed: 77% of the severe esophagitis individ-
uals in high-incidence areas had AG/GG genotypes
(Figure 3B), versus only 37% of these subjects in
low-incidence areas (Figure 3C) (OR 6.03 with 95%
CI 1.59–22.9 vs. OR 0.74 with 95% CI 0.33–1.64;
P ¼ 0.008; Table 1). These data support the hypoth-
esis that the interaction of potential environmental
factors with PLCe, particularly in the individuals
with AG or GG allele, not only exists in high-inci-
dence areas for esophageal cancer development in
China, but also correlates with the severity of esoph-
agitis. Currently, this group of individuals is under
long-term follow up. Correlations between this risk
allele, esophagitis, and cancer development will be
clarified in future studies.
In conclusion, PLCe is likely to play a pivotal role
in esophageal carcinogenesis: the presence of the
5780G allele may not only predict a high risk of fu-
ture esophageal cancer development, but may also
participate in esophageal cancer growth and pro-
gression by upregulating levels of PLCe mRNA, pro-
tein, and enzyme activity, ultimately leading to
augmentation of the inflammatory process in esoph-
ageal epithelium. Thus, the 5780G allele in PLCe
may constitute a promising biomarker for esophage-
al squamous carcinoma risk stratification, early
detection, and progression prediction.
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